Disc Medicine (IRON) Equity Ratio (2020 - 2026)

Disc Medicine (IRON) has 7 years of Equity Ratio data on file, last reported at 0.92 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.92, down 1.44% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.92 (down 1.44% YoY), and the FY2025 annual result was 0.92, up 2.68% from the prior year.
• Equity Ratio held at 0.92 in Q1 2026 per IRON's latest filing, from 0.92 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.97 in Q2 2023 and troughed at 0.93 in Q3 2022.
• A 5-year average of 0.63 and a median of 0.92 in 2025 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2022 and 2023: Equity Ratio sank 202.6% in 2022, then soared 261.15% in 2023.
• A 5-year view of Equity Ratio shows it stood at 0.88 in 2022, then gained by 6.32% to 0.94 in 2023, then fell by 4.79% to 0.89 in 2024, then rose by 2.68% to 0.92 in 2025, then climbed by 0.08% to 0.92 in 2026.
• Business Quant data shows IRON's Equity Ratio at 0.92 in Q1 2026, 0.92 in Q4 2025, and 0.91 in Q3 2025.